Apex Scientific

21+ access.
Research use only.

Before entering, confirm that you meet the age requirement and understand the research-use limitations that apply to every Apex product.

If provided, your email can be carried into checkout for convenience. It is not required to browse and does not subscribe you to marketing. Read the Privacy Notice, Research Use Policy, and Terms.

Leave site

Your acknowledgement is remembered on this device for 30 days.

Research use only Clear product information Free shipping on orders over $200 20% launch offer · Use code APEX101
Apex Scientific
SearchBag

Compound guide

CJC-1295 / IPAMORELIN

A pathway-focused guide to molecular mechanisms, published evidence, and the limits of interpretation.

Overview

A Summary:CJC-1295 / IPAMORELIN

This blend combines CJC-1295, a long-acting GHRH analogue, with ipamorelin, a growth-hormone secretagogue that acts through the ghrelin receptor pathway.

The two components are studied as distinct inputs into pituitary growth-hormone signaling: CJC-1295 through GHRH receptors and ipamorelin through growth-hormone secretagogue receptors.

The individual compounds have mechanistic and limited human exposure data, but that does not establish the safety or efficacy of this fixed research blend for any human purpose.

Research model

Cellular & MolecularHow CJC-1295 / IPAMORELIN Is Studied

These receptors, enzymes, and signaling networks define the primary laboratory questions associated with this research material.

01CJC-1295 input

GHRH receptor

At the cellular or molecular level

CJC-1295 is a GHRH analogue. Binding to the Gs-coupled GHRH receptor raises cyclic AMP and protein kinase A activity in pituitary somatotroph cells, supporting growth-hormone synthesis and release.

02Ipamorelin input

Ghrelin receptor / GHSR1a

At the cellular or molecular level

Ipamorelin activates the growth-hormone secretagogue receptor. This receptor mainly signals through Gq proteins, phospholipase C, intracellular calcium, and related pathways that trigger hormone release.

03Shared downstream effect

GH / IGF-1 axis

At the cellular or molecular level

Growth hormone released from the pituitary acts on liver and peripheral tissues through JAK2 and STAT signaling. Liver production of IGF-1 is one measurable downstream response.

Research interpretation

How to read the pathway.

01

CJC-1295 input

CJC-1295 is a GHRH analogue.

02

Ipamorelin input

Ipamorelin activates the growth-hormone secretagogue receptor.

03

Shared downstream effect

Growth hormone released from the pituitary acts on liver and peripheral tissues through JAK2 and STAT signaling.

Evidence boundary

The individual compounds have mechanistic and limited human exposure data, but that does not establish the safety or efficacy of this fixed research blend for any human purpose.

Read the evidence

Sources BehindThis Guide

CJC-1295 pharmacology study (opens in a new tab)Ipamorelin receptor research (opens in a new tab)CJC-1295 identity record (opens in a new tab)Ipamorelin identity record (opens in a new tab)

One important note

Educational Notice

Small human studies measured hormone changes from CJC-1295, while ipamorelin evidence is primarily receptor and pharmacology research. The fixed blend has not been evaluated in controlled human outcome trials.

This guide summarizes molecular mechanisms, published evidence, and evidence limits in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.